Key Highlights From the Annual Symposium of the American Society of Spine Radiology
In a recent video interview, Kevin J. Abrams, MD, discussed highlights from the recent 25th Annual Symposium of the American Society of Spine Radiology (ASSR), including lectures on imaging for spontaneous intracranial hypotension, the emergence of dynamic susceptibility contrast for MR perfusion and insights on the use of dual-energy computed tomography (CT) for diagnosing vertebral fractures.
While magnetic resonance (MR) perfusion is not exactly new, Kevin J. Abrams, MD, says the potential of dynamic susceptibility contrast with MR perfusion is exciting as it “allows you to hopefully differentiate active spine disease versus treated spine disease in a patient who has metastatic cancer.”
This was just one of the takeaways Dr. Abrams had after attending the 25th Annual Symposium of the American Society of Spine Radiology (ASSR). In a recent video interview with Diagnostic Imaging, Dr. Abrams also praised discussions of imaging for spontaneous intracranial hypotension (SIH). In addition to learning more about the risk of superficial siderosis in patients with this condition, he noted strong lectures on the use of CT myelography and digital subtraction myelography to diagnose different types of cerebrospinal fluid (CSF) leaks associated with SIH.
Dr. Abrams said another highlight talk was a lecture on the use of dual-energy CT to differentiate between acute and chronic vertebral fractures. He added that he started to incorporate this modality more in his practice shortly after attending the ASSR conference. The combination of artificial intelligence and augmented reality, as discussed at the ASSR meeting, has the potential to supplant procedure videos in the training of radiologists as it “feels like you’re doing the procedure before you do the procedure,” noted Dr. Abrams, the chief of radiology at Baptist Hospital of Miami, and a clinical associate professor of radiology at the Herbert Wertheim School of Medicine at Florida International University.
For additional insights from Dr. Abrams about the ASSR conference, watch the video below:
FDA Clears Enhanced MRI-Guided Laser Ablation System
June 5th 2025An alternative to an open neurosurgical approach, the Visualase V2 MRI-Guided Laser Ablation System reportedly utilizes laser interstitial thermal therapy (LITT) for targeted soft tissue ablation in patients with brain tumors and focal epilepsy.
Can Abbreviated MRI Have an Impact in Differentiating Intraductal Papilloma and Ductal Secretion?
June 3rd 2025For patients with inconclusive ultrasound results, abbreviated breast MRI offers comparable detection of intraductal papilloma as a full breast MRI protocol at significantly reduced times for scan acquisition and interpretation, according to a new study.
FDA Issues Expanded Pediatric Approval of MRI Contrast Agent for Lung Ventilation Assessment
June 2nd 2025Previously approved for MRI lung ventilation evaluation in adults and children 12 and older, the hyperpolarized contrast agent Xenoview can now be utilized for pediatric patients six years and older.
